What sector does Arvee Laboratories I Ltd belong to?

Arvee Laboratories I Ltd operates in the Commodities sector, specifically the Specialty Chemicals industry, and is listed on the NSE.

What is the current share price of ARVEE?

As of the latest available quote, ARVEE traded at ₹177.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of ARVEE?

Arvee Laboratories I Ltd has a price-to-earnings (P/E) ratio of about 47.97. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of ARVEE?

The market capitalisation of Arvee Laboratories I Ltd is approximately ₹199 Cr.

Is Arvee Laboratories I Ltd profitable?

For its latest reported financial year, Arvee Laboratories I Ltd recorded a net profit margin of about 8.03%.

Does ARVEE pay a dividend?

Arvee Laboratories I Ltd does not currently show a dividend yield in our data.

What is the return on equity (ROE) of ARVEE?

Arvee Laboratories I Ltd has a return on equity (ROE) of about 7.32%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of ARVEE?

Over the past 52 weeks, ARVEE has traded between a low of ₹129.11 and a high of ₹290.78.

Arvee Laboratories I Ltd

ARVEE NSE Commodities Specialty Chemicals

₹177.00

-9.35%

Delayed · cached 15 min

Fair value analysis

ARVEE

Arvee Laboratories I Ltd

₹195.25

Close used for this calculation

₹61.54Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

42/100

Profitability19/25

Returns2/25

Balance Sheet13/25

Efficiency8/25

Growth12/25

Average

Quality radar

Consensus fair value

₹61.54

Above FV

▼ -68.5% against the close used

Model range ₹17.46 – ₹103.58

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹17.46Fair value₹61.54Bull₹103.58

FairClose

52-week traded range

52W low ₹133.8652W high ₹290.78

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Arvee Laboratories I Ltd closed at ₹195.25, 217.3% above the consensus fair value of ₹61.54 drawn from 9 valuation models.

Financial DNA score 42/100 — Average. P/E of 49.2x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹45.65

-76.6%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

₹52.33

-73.2%

√(22.5 × EPS × BVPS)

EPS=2.3, BVPS=52.91 · outside Graham range (P/E 49.2, P/B 3.7) — asset-light, treat as a rough floor

Graham Formula

₹103.58

-46.9%

EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate

g=20%, FD=7%

P/E Fair Value

₹68.77

-64.8%

EPS × 29.9x (sector P/E)

EPS=2.3, Sector P/E=29.9x

Peter Lynch (PEG)

₹57.50

-70.6%

EPS × Growth% (PEG = 1 is fair)

EPS=2.3, g=25%

EV/EBITDA

₹69.66

-64.3%

(EBITDA × 18x − Net Debt) ÷ Shares

EBITDA=40M

Book Value (P/B)

₹17.46

-91.1%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=52.91, ROE=7.3%, g=6%, r=10%

Reverse DCF

₹195.25

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 26.8% | Historical: 25%

Margin of Safety

₹50.69

-74.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=67.58, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer